Immobilization of -Galactosidases on the Lactobacillus Cell Surface
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
An Antifungal Chitosanase from Bacillus Subtilis SH21
molecules Article An Antifungal Chitosanase from Bacillus subtilis SH21 Yuanxiang Pang 1, Jianjun Yang 1, Xinyue Chen 1, Yu Jia 1, Tong Li 1, Junhua Jin 1, Hui Liu 1, Linshu Jiang 1, Yanling Hao 2, Hongxing Zhang 1,* and Yuanhong Xie 1,* 1 Key Laboratory of Agricultural Product Detection and Control of Spoilage Organisms and Pesticides, Beijing Laboratory for Food Quality and Safety, Beijing Engineering Laboratory of Probiotics Key Technology Development, Beijing Engineering Technology Research Center of Food Safety Immune Rapid Detection, Food Science and Engineering College, Beijing University of Agriculture, Beijing 102206, China; [email protected] (Y.P.); [email protected] (J.Y.); [email protected] (X.C.); [email protected] (Y.J.); [email protected] (T.L.); [email protected] (J.J.); [email protected] (H.L.); [email protected] (L.J.) 2 Key Laboratory of Functional Dairy Science of Beijing and Chinese Ministry of Education, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, China; [email protected] * Correspondence: [email protected] (H.Z.); [email protected] (Y.X.) Abstract: Bacillus subtilis SH21 was observed to produce an antifungal protein that inhibited the growth of F. solani. To purify this protein, ammonium sulfate precipitation, gel filtration chromatogra- phy, and ion-exchange chromatography were used. The purity of the purified product was 91.33% ac- cording to high-performance liquid chromatography results. Sodium dodecyl sulfate–polyacrylamide gel electrophoresis and liquid chromatography–tandem mass spectrometry (LC–MS/MS) analysis revealed that the molecular weight of the protein is 30.72 kDa. The results of the LC–MS/MS analy- sis and a subsequent sequence-database search indicated that this protein was a chitosanase, and thus, we named it chitosanase SH21. -
Updating the Sequence-Based Classification of Glycosyl Hydrolases
Article Updating the sequence-based classification of glycosyl hydrolases HENRISSAT, Bernard, BAIROCH, Amos Marc Reference HENRISSAT, Bernard, BAIROCH, Amos Marc. Updating the sequence-based classification of glycosyl hydrolases. Biochemical Journal, 1996, vol. 316 ( Pt 2), p. 695-6 PMID : 8687420 DOI : 10.1042/bj3160695 Available at: http://archive-ouverte.unige.ch/unige:36909 Disclaimer: layout of this document may differ from the published version. 1 / 1 Biochem. J. (1996) 316, 695–696 (Printed in Great Britain) 695 BIOCHEMICAL JOURNAL Updating the sequence-based classification of available. When the number of glycosyl hydrolase sequences reached C 480, ten additional families (designated 36–45) could glycosyl hydrolases be defined and were added to the classification [2]. There are at present over 950 sequences of glycosyl hydrolases in the data- A classification of glycosyl hydrolases based on amino-acid- banks (EMBL}GenBank and SWISS-PROT). Their analysis sequence similarities was proposed in this Journal a few years shows that the vast majority of the C 470 additional sequences ago [1]. This classification originated from the analysis of C 300 that have become available since the last update could be classified sequences and their grouping into 35 families designated 1–35. in the existing families. However, several sequences not fitting Because such a classification is necessarily sensitive to the sample, the existing families allow the definition of new families (desig- it was anticipated that it was incomplete and that new families nated 46–57) (Table 1). When the several present genome would be determined when additional sequences would become sequencing projects have reached completion, the number of Table 1 New families in the classification of glycosyl hydrolases Family Enzyme Organism SWISS-PROT EMBL/GenBank 46 Chitosanase Bacillus circulans MH-K1 P33673 D10624 46 Chitosanase Streptomyces sp. -
Pdf 258.73 K
Iran J Biotech. 2015 December;13(4): e1175 DOI:10.15171/ijb.1175 Research Article An Alternative Bacterial Expression System Using Bacillus pumilus SG2 Chitinase Promoter Kambiz Morabbi Heravi 1, Garshasb Rigi 2, Maryam Rezaei Arjomand 3, Amin Rostami 3, Gholamreza Ahmadian 3,* 1Institut für Industrielle Genetik, Universität Stuttgart, Allmandring 31, 70569 Stuttgart, Germany 2Department of Biology, Faculty of Science, Behbahan Khatam Alanbia University of Technology, Behbahan, Iran 3Department of Industrial and Environmental Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran *Corresponding author: Gholamreza Ahmadian, Department of Industrial and Environmental Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran. Tel: +98-2144787301-10, Fax: +98-2144787399, E-mail: [email protected] Received: April 27, 2015; Revised: September 20, 2015; Accepted: October 03, 2015 Background: Chitin is an abundant natural polysaccharide found in fungi, algae, and exoskeleton of insects. Several bac- terial species are capable of utilizing chitin as their carbon source. These bacteria produce chitinases for degradation of chitin into N-acetyl-D-glucosamine. So far, regulation of the chitinase encoding genes has been studied in different bacte- rial species. Among Bacillus species, B. pumilus strain SG2 encodes two chitinases, ChiS and ChiL. The promoter region of chiSL genes (PchiS) is mainly regulated by the general carbon catabolite repression (CCR) system in B. subtilis due to the presence of a catabolite responsive element (cre). Objectives: Use of PchiS in constructing an inducible expression system in B. subtilis was investigated. Materials and Methods: In the first step, complete and shortened versions of PchiS were inserted upstream of the lacZ on a pBS72/pUC18 shuttle plasmid. -
Targeting the Tryptophan Hydroxylase 2 Gene for Functional Analysis in Mice and Serotonergic Differentiation of Embryonic Stem Cells
TARGETING THE TRYPTOPHAN HYDROXYLASE 2 GENE FOR FUNCTIONAL ANALYSIS IN MICE AND SEROTONERGIC DIFFERENTIATION OF EMBRYONIC STEM CELLS Inaugural-Dissertation to obtain the academic degree Doctor rerum naturalium (Dr. rer. nat.) submitted to the Department of Biology, Chemistry and Pharmacy of Freie Universität Berlin by Dana Kikic, M.Sc. in Molecular biology and Physiology from Nis June, 2009 The doctorate studies were performed in the research group of Prof. Michael Bader Molecular Biology of Peptide Hormones at Max-Delbrück-Center for Molecular Medicine in Berlin, Buch Mai 2005 - September 2008. 1st Reviewer: Prof. Michael Bader 2nd Reviewer: Prof. Udo Heinemann date of defence: 13. August 2009 ACKNOWLEDGMENTS Herewith, I would like to acknowledge the persons who made this thesis possible and without whom my initiation in the world of basic science research would not have the spin it has now, neither would my scientific illiteracy get the chance to eradicate. I am expressing my very personal gratitude and recognition to: Prof. Michael Bader, for an inexhaustible guidance in all the matters arising during the course of scientific work, for an instinct in defining and following the intellectual challenge and for letting me following my own, for necessary financial support, for defining the borders of reasonable and unreasonable, for an invaluable time and patience, and an amazing efficiency in supporting, motivating, reading, correcting and shaping my scientific language during the last four years. Prof. Harald Saumweber and Prof. Udo Heinemann, for taking over the academic supervision of the thesis, and for breathing in it a life outside the laboratory walls and their personal signature. -
Functional Analysis of Chimeric Lysin Motif Domain Receptors Mediating Nod Factor-Induced Defense Signaling in Arabidopsis Thali
The Plant Journal (2014) 78, 56–69 doi: 10.1111/tpj.12450 Functional analysis of chimeric lysin motif domain receptors mediating Nod factor-induced defense signaling in Arabidopsis thaliana and chitin-induced nodulation signaling in Lotus japonicus Wei Wang1,2, Zhi-Ping Xie1,* and Christian Staehelin1,* 1State Key Laboratory of Biocontrol and Guangdong Key Laboratory of Plant Resources, School of Life Sciences, Sun Yat-sen University, East Campus, Guangzhou 510006, China, and 2Anhui Key Laboratory of Plant Genetics & Breeding, School of Life Sciences, Anhui Agricultural University, 130 Changjiang West Road, Hefei, Anhui 230036, China Received 12 October 2013; revised 11 January 2014; accepted 16 January 2014; published online 8 February 2014. *For correspondence (e-mails [email protected] or [email protected]). SUMMARY The expression of chimeric receptors in plants is a way to activate specific signaling pathways by corre- sponding signal molecules. Defense signaling induced by chitin from pathogens and nodulation signaling of legumes induced by rhizobial Nod factors (NFs) depend on receptors with extracellular lysin motif (LysM) domains. Here, we constructed chimeras by replacing the ectodomain of chitin elicitor receptor kinase 1 (AtCERK1) of Arabidopsis thaliana with ectodomains of NF receptors of Lotus japonicus (LjNFR1 and LjNFR5). The hybrid constructs, named LjNFR1–AtCERK1 and LjNFR5–AtCERK1, were expressed in cerk1-2, an A. thaliana CERK1 mutant lacking chitin-induced defense signaling. When treated with NFs from Rhizobi- um sp. NGR234, cerk1-2 expressing both chimeras accumulated reactive oxygen species, expressed chitin- responsive defense genes and showed increased resistance to Fusarium oxysporum. In contrast, expression of a single chimera showed no effects. -
United States Patent (19) 11 Patent Number: 5,981,835 Austin-Phillips Et Al
USOO598.1835A United States Patent (19) 11 Patent Number: 5,981,835 Austin-Phillips et al. (45) Date of Patent: Nov. 9, 1999 54) TRANSGENIC PLANTS AS AN Brown and Atanassov (1985), Role of genetic background in ALTERNATIVE SOURCE OF Somatic embryogenesis in Medicago. Plant Cell Tissue LIGNOCELLULOSC-DEGRADING Organ Culture 4:107-114. ENZYMES Carrer et al. (1993), Kanamycin resistance as a Selectable marker for plastid transformation in tobacco. Mol. Gen. 75 Inventors: Sandra Austin-Phillips; Richard R. Genet. 241:49-56. Burgess, both of Madison; Thomas L. Castillo et al. (1994), Rapid production of fertile transgenic German, Hollandale; Thomas plants of Rye. Bio/Technology 12:1366–1371. Ziegelhoffer, Madison, all of Wis. Comai et al. (1990), Novel and useful properties of a chimeric plant promoter combining CaMV 35S and MAS 73 Assignee: Wisconsin Alumni Research elements. Plant Mol. Biol. 15:373-381. Foundation, Madison, Wis. Coughlan, M.P. (1988), Staining Techniques for the Detec tion of the Individual Components of Cellulolytic Enzyme 21 Appl. No.: 08/883,495 Systems. Methods in Enzymology 160:135-144. de Castro Silva Filho et al. (1996), Mitochondrial and 22 Filed: Jun. 26, 1997 chloroplast targeting Sequences in tandem modify protein import specificity in plant organelles. Plant Mol. Biol. Related U.S. Application Data 30:769-78O. 60 Provisional application No. 60/028,718, Oct. 17, 1996. Divne et al. (1994), The three-dimensional crystal structure 51 Int. Cl. ............................. C12N 15/82; C12N 5/04; of the catalytic core of cellobiohydrolase I from Tricho AO1H 5/00 derma reesei. Science 265:524-528. -
Characterization of a Chitinase and an Endo-Β-1,3-Glucanase from Trichoderma Harzianum Rifai T24 Involved in Control of the Phytopathogen Sclerotium Rolfsii
Appl Microbiol Biotechnol (2001) 56:137–143 DOI 10.1007/s002530100646 ORIGINAL PAPER M.H. El-Katatny · M. Gudelj · K.-H. Robra M.A. Elnaghy · G.M. Gübitz Characterization of a chitinase and an endo-β-1,3-glucanase from Trichoderma harzianum Rifai T24 involved in control of the phytopathogen Sclerotium rolfsii Received: 23 November 2000 / Received revision: 26 January 2001 / Accepted: 26 January 2001 / Published online: 19 May 2001 © Springer-Verlag 2001 Abstract Of 24 Trichoderma isolates, T. harzianum causes disease in over 500 plant species. Recently, the Rifai (T24) showed a potential for control of the phyto- fungus has also been found in Europe on different hosts, pathogenic basidiomycete Sclerotium rolfsii. When T24 including juglans and sunflowers (Belisario and Corazza was grown on different carbon sources, growth inhibi- 1996; Infantino et al. 1997). Mycoparasitic fungi have tion of S. rolfsii by the T24 culture filtrate correlated been shown to have a potential for the control of plant with the activity of extracellular chitinase and β-1,3- diseases caused by S. rolfsii (Maoa et al. 2000). Lectins glucanase. The 43-kilodalton (kDa) chitinase and the of S. rolfsii were found to be the recognition signal initi- 74-kDa β-1,3-glucanase were purified from the T24 cul- ating the coiling process in Trichoderma harzianum ture filtrate in two and three steps, respectively, using (Inbar and Chet 1995) (Fig. 1), while it has been sug- ammonium sulphate precipitation followed by hydropho- gested that constitutive carbohydrolases of T. harzianum bic interaction chromatography (phenyl-Sepharose) and release oligosaccharides from Rhizoctonia solani cell β gel filtration ( -1,3-glucanase). -
Flavonoid Glucodiversification with Engineered Sucrose-Active Enzymes Yannick Malbert
Flavonoid glucodiversification with engineered sucrose-active enzymes Yannick Malbert To cite this version: Yannick Malbert. Flavonoid glucodiversification with engineered sucrose-active enzymes. Biotechnol- ogy. INSA de Toulouse, 2014. English. NNT : 2014ISAT0038. tel-01219406 HAL Id: tel-01219406 https://tel.archives-ouvertes.fr/tel-01219406 Submitted on 22 Oct 2015 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Last name: MALBERT First name: Yannick Title: Flavonoid glucodiversification with engineered sucrose-active enzymes Speciality: Ecological, Veterinary, Agronomic Sciences and Bioengineering, Field: Enzymatic and microbial engineering. Year: 2014 Number of pages: 257 Flavonoid glycosides are natural plant secondary metabolites exhibiting many physicochemical and biological properties. Glycosylation usually improves flavonoid solubility but access to flavonoid glycosides is limited by their low production levels in plants. In this thesis work, the focus was placed on the development of new glucodiversification routes of natural flavonoids by taking advantage of protein engineering. Two biochemically and structurally characterized recombinant transglucosylases, the amylosucrase from Neisseria polysaccharea and the α-(1→2) branching sucrase, a truncated form of the dextransucrase from L. Mesenteroides NRRL B-1299, were selected to attempt glucosylation of different flavonoids, synthesize new α-glucoside derivatives with original patterns of glucosylation and hopefully improved their water-solubility. -
Structural Engineering of a Phage Lysin That Targets Gram-Negative Pathogens
Structural engineering of a phage lysin that targets Gram-negative pathogens Petra Lukacika, Travis J. Barnarda, Paul W. Kellerb, Kaveri S. Chaturvedic, Nadir Seddikia,JamesW.Fairmana, Nicholas Noinaja, Tara L. Kirbya, Jeffrey P. Hendersonc, Alasdair C. Stevenb, B. Joseph Hinnebuschd, and Susan K. Buchanana,1 aLaboratory of Molecular Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892; bLaboratory of Structural Biology, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda,MD 20892; cCenter for Women’s Infectious Diseases Research, Washington University School of Medicine, St. Louis, MO 63110; and dLaboratory of Zoonotic Pathogens, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840 Edited by* Brian W. Matthews, University of Oregon, Eugene, OR, and approved April 18, 2012 (received for review February 27, 2012) Bacterial pathogens are becoming increasingly resistant to antibio- ∼10 kb plasmid called pPCP1 (7). Pla facilitates invasion in bu- tics. As an alternative therapeutic strategy, phage therapy reagents bonic plague and, as such, is an important virulence factor (8, 9). containing purified viral lysins have been developed against Gram- When strains lose the pPCP1 plasmid, they are killed by pesticin positive organisms but not against Gram-negative organisms due thus ensuring maximal virulence in the bacterial population. to the inability of these types of drugs to cross the bacterial outer Bacteriocins belong to two classes. Type A bacteriocins depend membrane. We solved the crystal structures of a Yersinia pestis on the Tolsystem to traverse the outer membrane, whereas type B outer membrane transporter called FyuA and a bacterial toxin bacteriocins require the Ton system. -
N-Acetylglucosamine: Production and Applications
Mar. Drugs 2010, 8, 2493-2516; doi:10.3390/md8092493 OPEN ACCESS Marine Drugs ISSN 1660-3397 www.mdpi.com/journal/marinedrugs Review N-Acetylglucosamine: Production and Applications Jeen-Kuan Chen 1,†, Chia-Rui Shen 2,† and Chao-Lin Liu 3,* 1 Department of Environment and Biotechnology, Refining & Manufacturing Research Institute, CPC Corporation, 217 Min-Sheng S. Rd, Chiayi, Taiwan; E-Mail: [email protected] (J.-K.C.) 2 Department of Medical Biotechnology and Laboratory Science, Chang Gung University, Kweishan, Taoyuan, 259 Wen-Hwa 1st Road, Kweishan, Taoyuan, Taiwan; E-Mail: [email protected] (C.-R.S.) 3 Graduate School of Biochemical Engineering and Department of Chemical Engineering, Ming Chi University of Technology, Taishan, Taipei, 84 Gung-Juan Road, Taishan, Taipei, Taiwan † These authors contributed equally to this work. * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +886-2-2908-9899; Fax: +886-3-211-8698. Received: 22 March 2010; in revised form: 19 April 2010 / Accepted: 23 April 2010 / Published: 15 September 2010 Abstract: N-Acetylglucosamine (GlcNAc) is a monosaccharide that usually polymerizes linearly through (1,4)-β-linkages. GlcNAc is the monomeric unit of the polymer chitin, the second most abundant carbohydrate after cellulose. In addition to serving as a component of this homogeneous polysaccharide, GlcNAc is also a basic component of hyaluronic acid and keratin sulfate on the cell surface. In this review, we discuss the industrial production of GlcNAc, using chitin as a substrate, by chemical, enzymatic and biotransformation methods. Also, newly developed methods to obtain GlcNAc using glucose as a substrate in genetically modified microorganisms are introduced. -
Development of Phage Lysins As Novel Therapeutics: a Historical Perspective
viruses Essay Development of Phage Lysins as Novel Therapeutics: A Historical Perspective Vincent A. Fischetti ID Laboratory of Bacterial Pathogenesis and Immunology, The Rockefeller University, 1230 York Avenue, New York, NY 10065, USA; [email protected] Received: 10 May 2018; Accepted: 5 June 2018; Published: 7 June 2018 Abstract: Bacteriophage lysins and related bacteriolytic enzymes are now considered among the top antibiotic alternatives for solving the mounting resistance problem. Over the past 17 years, lysins have been widely developed against Gram-positive and recently Gram-negative pathogens, and successfully tested in a variety of animal models to demonstrate their efficacy. A lysin (CF-301) directed to methicillin resistant Staphylococcus aureus (MRSA) has effectively completed phase 1 human clinical trials, showing safety in this novel therapeutic class. To validate efficacy, CF-301 is currently the first lysin to enter phase 2 human trials to treat hospitalized patients with MRSA bacteremia or endocarditis. If successful, it could be the defining moment leading to the acceptance of lysins as an alternative to small molecule antibiotics. This article is a detailed account of events leading to the first therapeutic use and ultimate development of phage-encoded lysins as novel anti-infectives. Keywords: phage; lysins; endolysins; lytic enzymes; discovery; therapeutic; antibiotic resistance; alternative to antibiotics 1. Preface Since 2001, when our first paper was published describing the in vivo use of phage enzymes as potential therapeutics, I have been asked many times: “How did you think of doing this?” This article is a detailed answer to that question. I certainly was not the only person in the world working on phage lysins at the time; however, I was one of the few working with a highly-active lysin against Gram-positive bacteria. -
Mapping the Transglycosylation Relevant Sites of Cold-Adapted -D
International Journal of Molecular Sciences Article Mapping the Transglycosylation Relevant Sites of Cold-Adapted β-d-Galactosidase from Arthrobacter sp. 32cB Maria Rutkiewicz 1,2,* , Marta Wanarska 3 and Anna Bujacz 1 1 Institute of Molecular and Industrial Biotechnology, Faculty of Biotechnology and Food Sciences, Lodz University of Technology, Stefanowskiego 4/10, 90-924 Lodz, Poland; [email protected] 2 Macromolecular Structure and Interaction, Max Delbrück Center for Molecular Medicine, Robert-Rössle-Straße 10, 13125 Berlin, Germany 3 Department of Molecular Biotechnology and Microbiology, Faculty of Chemistry, Gdansk University of Technology, Narutowicza 11/12, 80-233 Gdansk, Poland; [email protected] * Correspondence: [email protected] Received: 30 June 2020; Accepted: 24 July 2020; Published: 28 July 2020 Abstract: β-Galactosidase from Arthrobacter sp. 32cB (ArthβDG) is a cold-adapted enzyme able to catalyze hydrolysis of β-d-galactosides and transglycosylation reaction, where galactosyl moiety is being transferred onto an acceptor larger than a water molecule. Mutants of ArthβDG: D207A and E517Q were designed to determine the significance of specific residues and to enable formation of complexes with lactulose and sucrose and to shed light onto the structural basis of the transglycosylation reaction. The catalytic assays proved loss of function mutation E517 into glutamine and a significant drop of activity for mutation of D207 into alanine. Solving crystal structures of two new mutants, and new complex structures of previously presented mutant E441Q enables description of introduced changes within active site of enzyme and determining the importance of mutated residues for active site size and character.